Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SNRS- Sunrise Technologies -- Ignore unavailable to you. Want to Upgrade?

To: Harry N who wrote (2154)	3/9/1999 8:19:00 PM
From: majormember	Read Replies (2) \| Respond to of 4140

Harry, Would you be kind enough to mention the radio station and city the SNRS debate is on. I would be most interested in a radio station that has not just one, but two host's taking opposite views on the speculative merits of SNRS. As to price upon approval, the TA's I have spoken with feel we could revisit the all time high of 24 1/2. Of course, if Wall Street starts building "Castles in the Air", we could go higher. Conversely, there are no gurantees on how the procedure will be accepted after FDA approval, hence we could fall short of revisiting 24 1/2. Regards, Skane

To: Harry N who wrote (2154)	3/16/1999 7:03:00 AM
From: Duke	Read Replies (2) \| Respond to of 4140

Hi Harry - Haven't been here for awhile and this is the first I've read your post. I appreciate your having a value in my opinion; good or bad here's a dollar/risk/competition to payoff perspective: Sort of philosophical... VISX in reality is trading as have today over $150 a share (taking the split into consideration) and I am only aware of 1. SNRS is trading at less than $10. Question: What is the potential value of SNRS stock? These are the two players for the eye care treatment of this kind. VISIX has the FDA approvals and SNRS does not. VISIX is in the money.... And is paving the way for a competitive treatment, both market and consumer acceptance is implied here which is taking place and gaining momentum.... I wonder what if that competitive treatment was more effective, less expensive to the consumer and the machine that administered the treatment (of course being operated by a highly skilled, specialized Dr.) was also superior and less expensive for the Dr. to purchase.... Was available through another company! Would you want stock in that company? I said Yahoo yes! Everything rides on the FDA approval though... The FDA risk Vs the reward isn't high enough to discourage me. It is possible that the approval will not happen. And it is also possible that the Y2K concerns are going to screw up everything, effecting Corp earnings, air traffic control, the utilities, etc. Is it probable? And if that happens, somehow the problems will be fixed and we will go on. So if SNRS doesn't make it the 1st round of approvals, the stock drops to $1.50, ultimately & eventually they'll get it right...(wishful thinking, nothing to confirm this view from SNRS) is my ultimate downside risk next to writing the entire investment off as a loss. I can live with that, can you afford to expose money to this kind of speculative investment? That's a question for you to answer. Well Harry; speculative is what was said about Yahoo and I missed it. Yahoo to you Harry, Regards, Duke